Active

C.E.R. - CLINICAL ENGINEERING & RESEARCH

Switched

BE0425363905

Rechtspersoon Private limited company 1 establishment

Bogaertstraat 24, 9830 Sint-Martens-Latem Activiteiten van holdings

Active for

42 year, 8 months

Financials

Financial year 2025

Gross margin

€ 1.2 million

▲ 4% vs 2024

Profit

Growing

€ 197,395

▲ 22% vs 2024

Debts

Low

€ 3.6 million

▼ 8% vs 2024

C.E.R. - CLINICAL ENGINEERING & RESEARCH from Sint-Martens-Latem, company number BE0425363905, closed financial year 2025 with a result of € 197,395 after tax. For that financial year C.E.R. - CLINICAL ENGINEERING & RESEARCH recorded a gross margin of € 1.2 million and equity of € 13.3 million. Compared with financial year 2024, the result moved from € 161,816 to € 197,395. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What happened at C.E.R. - CLINICAL ENGINEERING & RESEARCH?

What happened at C.E.R. - CLINICAL ENGINEERING & RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 197,395 (▲ 22% vs 2024). Source: NBB ↗
  • New establishment in Sint-Martens-Latem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 161,816 profit in 2024 to € 197,395 profit in 2025.

Paid € 167,055 in corporate taxes since 2024.

Best year ever: 2025, with € 197,395 profit.

On average € 600,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at C.E.R. - CLINICAL ENGINEERING & RESEARCH? We notify you, reason included.

Follow C.E.R. - CLINICAL ENGINEERING & RESEARCH

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jan RUYSSCHAERT
Lieve VANHOUTEGHEM
C.E.R. - CLINICAL ENGINEERING & RESEARCH
L&J-Label 99.9%

Behind C.E.R. - CLINICAL ENGINEERING & RESEARCH are Jan RUYSSCHAERT and Lieve VANHOUTEGHEM. It owns 99.9% of L&J-Label itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan RUYSSCHAERT

Director

Also active at: RESIDENZ, L&J - label, HEB +7 more

Lieve VANHOUTEGHEM

Director

Also active at: FINAGRO, L&J - label, L&J Invest

Establishments

Establishment units

Physical locations of this company

Registered office

Bogaertstraat 24

9830 Sint-Martens-Latem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

L&J - label same network

€ 6,621 gross margin · 2025

BISMO

ART STUDIO L&J

DE BOGAARD

L&J Invest same network

€ 535,743 gross margin · 2025

Details

Company number
0425.363.905
VAT number
BE 0425.363.905
Registered office
Bogaertstraat 24, 9830 Sint-Martens-Latem
Names & denominations
C.E.R. - CLINICAL ENGINEERING & RESEARCH
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
20 December 1983
Peppol
Active · Active since 16 Dec 2025
Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
The enterprise number of C.E.R. - CLINICAL ENGINEERING & RESEARCH is BE0425363905.
What is the address of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
The registered office of C.E.R. - CLINICAL ENGINEERING & RESEARCH is located at Bogaertstraat 24, 9830 Sint-Martens-Latem.
When was C.E.R. - CLINICAL ENGINEERING & RESEARCH founded?
C.E.R. - CLINICAL ENGINEERING & RESEARCH was founded on 20 December 1983.
What is the main activity of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
The main activity of C.E.R. - CLINICAL ENGINEERING & RESEARCH is "Activiteiten van holdings" (NACE code 64210).
Does C.E.R. - CLINICAL ENGINEERING & RESEARCH have a website?
No website is currently known for C.E.R. - CLINICAL ENGINEERING & RESEARCH.
How much profit did C.E.R. - CLINICAL ENGINEERING & RESEARCH make in 2025?
C.E.R. - CLINICAL ENGINEERING & RESEARCH posted a profit after taxes of € 197,395 in financial year 2025.
What is the revenue of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
As a small company, C.E.R. - CLINICAL ENGINEERING & RESEARCH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,200,926.
How many employees does C.E.R. - CLINICAL ENGINEERING & RESEARCH have?
According to the 2025 annual accounts, C.E.R. - CLINICAL ENGINEERING & RESEARCH has 2 full-time equivalents (FTE).
Where can I find the annual accounts of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
C.E.R. - CLINICAL ENGINEERING & RESEARCH files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
According to the 2025 annual accounts, the directors of C.E.R. - CLINICAL ENGINEERING & RESEARCH are: Jan RUYSSCHAERT, Lieve VANHOUTEGHEM.
Who owns C.E.R. - CLINICAL ENGINEERING & RESEARCH?
Behind C.E.R. - CLINICAL ENGINEERING & RESEARCH are Jan RUYSSCHAERT and Lieve VANHOUTEGHEM. It owns 99.9% of L&J-Label itself.